Interaction and dynamics of chemokine receptor CXCR4 binding with CXCL12 and hBD-3

被引:2
|
作者
Penfield, Jackson [1 ]
Zhang, Liqun [2 ]
机构
[1] Tennessee Technol Univ, Chem Engn Dept, Cookeville, TN 38505 USA
[2] Univ Rhode Isl, Chem Engn Dept, Kingston, RI 02881 USA
来源
COMMUNICATIONS CHEMISTRY | 2024年 / 7卷 / 01期
基金
美国国家卫生研究院;
关键词
CRYSTAL-STRUCTURE; HUMAN BETA-DEFENSIN-3; MOLECULAR-DYNAMICS; PROTEIN; ACTIVATION; DIMERIZATION; EXPRESSION; CANCER; DISRUPTION; MODULATION;
D O I
10.1038/s42004-024-01280-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chemokine receptor CXCR4 is involved in diverse diseases. A comparative study was conducted on CXCR4 embedded in a POPC lipid bilayer binding with CXCL12 in full and truncated forms, hBD-3 in wildtype, analog, and mutant forms based on in total 63 mu s all-atom MD simulations. The initial binding structures of CXCR4 with ligands were predicted using HADDOCK docking or random-seed method, then mu s-long simulations were performed to refine the structures. CXCR4&ligand binding structures predicted agree with available literature data. Both kinds of ligands bind stably to the N-terminus, extracellular loop 2 (ECL2), and ECL3 regions of CXCR4; the C2-C3 (K32-R38) region and occasionally the head of hBD-3 bind stably with CXCR4. hBD-3 analogs with Cys11-Cys40 disulfide bond can activate CXCR4 based on the Helix3-Helix6 distance calculation, but not other analogs or mutant. The results provide insight into understanding the dynamics and activation mechanism of CXCR4 receptor binding with different ligands. The chemokine receptor CXCR4 is involved in cancers and diverse diseases, however, molecular details surrounding the binding of different ligands to this receptor remain incomplete. Here, the authors study the binding and interaction between CXCR4 with CXCL12 and hBD-3 in different forms, and find that both ligands can bind with CXCR4 at the same site, and analogs of hBD-3 with a Cys11-Cys40 disulfide bond can activate CXCR4.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4
    Kofuku, Yutaka
    Yoshiura, Chie
    Ueda, Takumi
    Terasawa, Hiroaki
    Hirai, Takahiro
    Tominaga, Sae
    Hirose, Masako
    Maeda, Yoshitake
    Takahashi, Hideo
    Terashima, Yuya
    Matsushima, Kouji
    Shimada, Ichio
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (50) : 35240 - 35250
  • [22] The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
    Garcia-Cuesta, Eva M.
    Santiago, Cesar A.
    Vallejo-Diaz, Jesus
    Juarranz, Yasmina
    Miguel Rodriguez-Frade, Jose
    Mellado, Mario
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [23] Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists
    Morimoto, Mamoru
    Matsuo, Yoichi
    Koide, Shuji
    Tsuboi, Ken
    Shamoto, Tomoya
    Sato, Takafumi
    Saito, Kenta
    Takahashi, Hiroki
    Takeyama, Hiromitsu
    BMC CANCER, 2016, 16
  • [24] Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
    Heinrich, Eileen L.
    Lee, Wendy
    Lu, Jianming
    Lowy, Andrew M.
    Kim, Joseph
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [25] Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis
    Tunc, Turan
    Cekmez, Ferhat
    Cetinkaya, Merih
    Kalayci, Tugce
    Fidanci, Kursat
    Saldir, Mehmet
    Babacan, Oguzhan
    Sari, Erkan
    Erdem, Galip
    Cayci, Tuncer
    Kul, Mustafa
    Kavuncuoglu, Sultan
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (03) : 356 - 361
  • [26] Role of CXCL12 and CXCR4 in normal cerebellar development and medulloblastoma
    Murobushi Ozawa, Patricia Midori
    Ariza, Carolina Batista
    Ishibashi, Cintya Mayumi
    Fujita, Thiago Cezar
    Banin-Hirata, Bruna Karina
    Maeda Oda, Julie Massayo
    Ehara Watanabe, Maria Angelica
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (01) : 10 - 13
  • [27] Is it possible to treat melanoma by intercepting the CXCR4/ CXCL12 pathway?
    Motlak, Miriam
    Mathews, Meghna
    Al-Odat, Omar S.
    Pandey, Manoj K.
    CYTOKINE, 2024, 179
  • [28] Sulfopeptide Probes of the CXCR4/CXCL12 Interface Reveal Oligomer-Specific Contacts and Chemokine Allostery
    Ziarek, Joshua J.
    Getschman, Anthony E.
    Butler, Stephen J.
    Taleski, Deni
    Stephens, Bryan
    Kufareva, Irina
    Handel, Tracy M.
    Payne, Richard J.
    Volkman, Brian F.
    ACS CHEMICAL BIOLOGY, 2013, 8 (09) : 1955 - 1963
  • [29] A review on CXCR4/CXCL12 axis in oncology: No place to hide
    Domanska, Urszula M.
    Kruizinga, Roeliene C.
    Nagengast, Wouter B.
    Timmer-Bosscha, Hetty
    Huls, Gerwin
    de Vries, Elisabeth G. E.
    Walenkamp, Annemiek M. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) : 219 - 230
  • [30] Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis
    Badr, Hassan S.
    El-Gendy, Fady M.
    Helwa, Mohamed A.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2018, 31 (16) : 2209 - 2215